Search

Your search keyword '"Costanzo, Antonio"' showing total 1,222 results

Search Constraints

Start Over You searched for: Author "Costanzo, Antonio" Remove constraint Author: "Costanzo, Antonio"
1,222 results on '"Costanzo, Antonio"'

Search Results

2. Long-Term Effectiveness and Safety of Ixekizumab for the Treatment of Moderate-to-Severe Plaque Psoriasis: A Five-Year Multicenter Retrospective Study—IL PSO (Italian Landscape Psoriasis)

6. Embedding Resilience to Climate Change and Natural Hazards in Smart Services

12. Implementation of regulatory guidance for JAK inhibitors use in patients with immune-mediated inflammatory diseases: An international appropriateness study

16. Autoinflammatory and autoimmune conditions at the crossroad of COVID-19

18. A Noise Mitigation Approach for VLC Systems

22. Association of disease duration and PASI response rates at week 12 in patients with moderate-to-severe plaque psoriasis receiving biologics in the real-world psoriasis study of health outcomes (PSoHO)

23. Successful use of tralokinumab for the treatment of atopic dermatitis on the genitals

24. Comparative effectiveness of tildrakizumab 200 mg versus tildrakizumab 100 mg in psoriatic patients with high disease burden or above 90 kg of body weight: a 16-week multicenter retrospective study – IL PSO (Italian landscape psoriasis)

25. Clinical outcomes and management of JAK inhibitor-associated acne in patients with moderate-to-severe atopic dermatitis undergoing upadacitinib: A multicenter retrospective study

26. Sorafenib-Induced Acute Generalized Exanthematous Pustulosis

28. Effects of hospital facilities on patient outcomes after cancer surgery: an international, prospective, observational study

30. Seismic survey in urban area: the activities of the EMERSITO INGV emergency group in Ancona (Italy) following the 2022 MW 5.5 Costa Marchigiana-Pesarese earthquake.

31. Health-Related Quality of Life in Psoriasis: Literature Review.

32. Thin Amelanotic and Hypomelanotic Melanoma: Clinicopathological and Dermoscopic Features.

33. Splenic trauma: WSES classification and guidelines for adult and pediatric patients

34. Safety of Tralokinumab for the Treatment of Atopic Dermatitis in Patients with Up to 4.5 Years of Treatment: An Updated Integrated Analysis of Eight Clinical Trials

39. 555 - Safety of tralokinumab for the treatment of atopic dermatitis in patients with up to 4.5 years of treatment: an updated integrated analysis of eight clinical trials

42. Effectiveness of ixekizumab for the treatment of moderate‐to‐severe plaque psoriasis with involvement of difficult‐to‐treat areas: A 52‐week multicenter retrospective study

43. Effectiveness, Tolerability, and Drug Survival of Risankizumab in a Real-World Setting: A Three-Year Retrospective Multicenter Study—IL PSO (ITALIAN LANDSCAPE PSORIASIS)

44. Bimekizumab Continuous Maintenance of Eesponse at Every Visit Through Two Years in Patients with Moderate to Severe Plaque Psoriasis: Post-hoc Results from Five Phase 3/3b Trials

45. Treat-to-Target Approach for the Management of Patients with Moderate-to-Severe Plaque Psoriasis: Consensus Recommendations

46. Guselkumab: an anti-IL-23 antibody for the treatment of moderate-to-severe plaque psoriasis

49. Implementation of regulatory guidance for JAK inhibitors use in patients with immune-mediated inflammatory diseases: An international appropriateness study

Catalog

Books, media, physical & digital resources